Literature DB >> 30125355

Fluorescence-guided surgery for high-grade gliomas.

Nikita Lakomkin1,2, Constantinos G Hadjipanayis1,2.   

Abstract

5-aminolevulinic acid (5-ALA) is a prodrug that results in the fluorescence of high-grade gliomas relative to the surrounding brain parenchyma. 5-ALA has been increasingly utilized in fluorescence-guided surgery for these tumors, and its intraoperative use has been associated with a significantly improved extent of resection and progression-free survival. This review outlines the growing body of evidence that has culminated in the recent Food and Drug Administration approval of 5-ALA, as well as emerging applications for this agent.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  5-aminolevulinic acid (5-ALA); glioblastoma multiforme (GBM); photodynamic therapy

Mesh：

Substances：

Year:  2018        PMID： 30125355     DOI： 10.1002/jso.25154

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  20 in total

1.  5-ALA fluorescence-guided surgery of CNS tumors.

Authors:  Constantinos G Hadjipanayis; Walter Stummer; Jason P Sheehan
Journal:  J Neurooncol       Date:  2019-02       Impact factor: 4.130

2.  Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain.

Authors:  Collin T Inglut; Brandon Gaitan; Daniel Najafali; Irati Abad Lopez; Nina P Connolly; Seppo Orsila; Robert Perttilä; Graeme F Woodworth; Yu Chen; Huang-Chiao Huang
Journal:  Photochem Photobiol       Date:  2019-10-13       Impact factor: 3.421

Review 3.  Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.

Authors:  Edward V Maytin; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2020-04-15       Impact factor: 3.421

4.  C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.

Authors:  Junseong Park; Seung Jae Oh; Jin-Kyoung Shim; Young Bin Ji; Ju Hyung Moon; Eui Hyun Kim; Yong-Min Huh; Jin-Suck Suh; Jong Hee Chang; Su-Jae Lee; Seok-Gu Kang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

Review 5.  Fluorescence guided surgery for pituitary adenomas.

Authors:  Nikita Lakomkin; Jamie J Van Gompel; Kalmon D Post; Steve S Cho; John Y K Lee; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

6.  Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series.

Authors:  Rebecca B Baron; Nikita Lakomkin; Alexander J Schupper; Dominic Nistal; Kambiz Nael; Gabrielle Price; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2020-06-09       Impact factor: 4.130

7.  Intraoperative biophotonic imaging systems for image-guided interventions.

Authors:  Salar Sajedi; Hamid Sabet; Hak Soo Choi
Journal:  Nanophotonics       Date:  2018-12-14       Impact factor: 8.449

Review 8.  The Use of Spectroscopy Handheld Tools in Brain Tumor Surgery: Current Evidence and Techniques.

Authors:  Nikita Lakomkin; Constantinos G Hadjipanayis
Journal:  Front Surg       Date:  2019-05-29

Review 9.  Clinical development and potential of photothermal and photodynamic therapies for cancer.

Authors:  Xingshu Li; Jonathan F Lovell; Juyoung Yoon; Xiaoyuan Chen
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675

10.  Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial.

Authors:  Kathryn Ottolino-Perry; Anam Shahid; Stephanie DeLuca; Viktor Son; Mayleen Sukhram; Fannong Meng; Zhihui Amy Liu; Sara Rapic; Nayana Thalanki Anantha; Shirley C Wang; Emilie Chamma; Christopher Gibson; Philip J Medeiros; Safa Majeed; Ashley Chu; Olivia Wignall; Alessandra Pizzolato; Cheryl F Rosen; Liis Lindvere Teene; Danielle Starr-Dunham; Iris Kulbatski; Tony Panzarella; Susan J Done; Alexandra M Easson; Wey L Leong; Ralph S DaCosta
Journal:  Breast Cancer Res       Date:  2021-07-12       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.